CoChat

The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients*

Yatabe, Tomoaki, Yamazaki, Rie, Kitagawa, Hiroyuki, Okabayashi, Takehiro, Yamashita, Koichi, Hanazaki, Kazuhiro, Yokoyama, Masataka · 2011 · Critical Care Medicine
Cited by 73

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: Reduction in the variability of blood glucose concentration might be an important aspect of blood glucose management. A closed-loop glycemic control device (STG-22; NIKKISO, Tokyo, Japan) has been developed to maintain blood glucose levels within the target range through automatic infusion of insulin and glucose. We hypothesized that the STG-22 system could provide optimal blood glucose management without causing hypoglycemic events in patients admitted to intensive care units. In this study, we investigated the feasibility of glycemic control with the STG-22 system. Furthermore, we evaluated the variability in blood glucose concentration associated with the use of the STG-22 system. DESIGN: Retrospective analysis. SETTING: A five-bed medical/surgical intensive care unit in a university hospital. PATIENTS: Two hundred eight patients admitted to the intensive care unit between August 2006 and July 2009. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We calculated the mean and sd of blood glucose concentrations in each patient during intensive insulin therapy (target range, 90-110 mg/dL) administered using STG-22. In addition, to evaluate the blood glucose control achieved using STG-22, the durations for which the blood glucose level was maintained at 70-110 mg/dL, 110-150 mg/dL, 150-180 mg/dL, and>180 mg/dL were calculated. The average operation time of STG-22 was 33.9±42.4 hrs. The blood glucose level was maintained at 70-110 mg/dL for 49.5% of the study period; the corresponding values for 110-150 mg/dL, 150-180 mg/dL, and>180 mg/dL were 31.4%, 7.0%, and 6.9%, respectively. No hypoglycemic events occurred. The sd of blood glucose levels was 19.9±10.9 mg/dL. After a level of 150 mg/dL was achieved, the sd of blood glucose was 12.6±3.1 mg/dL. CONCLUSIONS: STG-22 can help maintain optimal blood glucose levels without causing hypoglycemia in patients admitted to the intensive care unit. In addition, the use of this device might help decrease the variability in blood glucose concentration. Further randomized clinical trials are required to elucidate whether the low glucose variability maintained using STG-22 can contribute to improving the outcomes of patients admitted to the intensive care unit.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ccm.0b013e318206b9ad

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 73

Metadata

Authors
Yatabe, T., Yamazaki, R., Kitagawa, H., Okabayashi, T., Yamashita, K., Hanazaki, K., & Yokoyama, M.
Venue
Critical Care Medicine
Published
2011-03
Volume
39
Issue
3
Pages
575-578
ISSN
0090-3493 (ISSN-L)
OpenAlex
W2320206374
Cited by
73
References
3
FWCI
3.96
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients*. https://app.cochat.ai/papers/10.1097/ccm.0b013e318206b9ad
The paper
Yatabe, T., Yamazaki, R., Kitagawa, H., Okabayashi, T., Yamashita, K., Hanazaki, K., & Yokoyama, M. (2011). The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients*. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e318206b9ad

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.